IL2 and graft versus host disease: Targeting IL-2 is nuanced by its dual roles, as in addition to promoting the T cell-mediated toxicity in GVHD, it is essential for the development and maintenance of Tregs which are important regulators of immune tolerance, and may in turn be employed in the prevention of GVHD (56–60).